These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8911878

  • 1. Effect of octreotide on blood glucose and counterregulatory hormones in insulin-dependent diabetic patients: the role of dose and route of administration.
    Lunetta M, De Mauro M, Le Moli R, Nicoletti F.
    Eur J Clin Pharmacol; 1996; 51(2):139-44. PubMed ID: 8911878
    [Abstract] [Full Text] [Related]

  • 2. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L, Sherwin R, Hendler R, Felig P.
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [Abstract] [Full Text] [Related]

  • 3. Lack of pharmacological effect of subcutaneous octreotide in an insulin-dependent diabetic patient: reversal after mixing with aprotinin.
    Lunetta M, Di Mauro M, Le Moli R.
    J Endocrinol Invest; 1997 Jun; 20(6):331-4. PubMed ID: 9294779
    [Abstract] [Full Text] [Related]

  • 4. Effect of octreotide on growth hormone, IGF-I, IGFBP-3, glucagon, cortisol and epinephrine response to insulin-induced hypoglycaemia in insulin-dependent diabetic patients.
    Lunetta M, Di Mauro M, Le Moli R, Nicoletti F.
    Diabetes Metab; 1997 Dec; 23(6):524-7. PubMed ID: 9496559
    [Abstract] [Full Text] [Related]

  • 5. Combination of continuous subcutaneous infusion of insulin and octreotide in Type 1 diabetic patients.
    Bruttomesso D, Fongher C, Silvestri B, Barberio S, Marescotti MC, Iori E, Valerio A, Crazzolara D, Pianta A, Tiengo A, Del Prato S.
    Diabetes Res Clin Pract; 2001 Feb; 51(2):97-105. PubMed ID: 11165689
    [Abstract] [Full Text] [Related]

  • 6. Effects of octreotide on glycaemic control, glucose disposal, hepatic glucose production and counterregulatory hormones secretion in type 1 and type 2 insulin treated diabetic patients.
    Lunetta M, Di Mauro M, Le Moli R, Nicoletti F.
    Diabetes Res Clin Pract; 1997 Nov; 38(2):81-9. PubMed ID: 9483371
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Symptoms, hormones, and glucose fluxes during a gradual hypoglycaemia induced by intraperitoneal vs venous insulin infusion in Type I diabetes.
    Selam JL, Medlej R, M'bemba J, Chevalier A, Guyon F, Ashworth L, Slama G.
    Diabet Med; 1995 Dec; 12(12):1102-9. PubMed ID: 8750221
    [Abstract] [Full Text] [Related]

  • 9. Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus.
    Spinas GA, Bock A, Keller U.
    Diabetes Care; 1985 Dec; 8(5):429-35. PubMed ID: 2865093
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of the somatostatin analog, octreotide, on glucose metabolism and insulin sensitivity in insulin-dependent diabetes mellitus.
    Orskov L, Møller N, Bak JF, Pørksen N, Schmitz O.
    Metabolism; 1996 Feb; 45(2):211-7. PubMed ID: 8596492
    [Abstract] [Full Text] [Related]

  • 13. Different effects of octreotide by continuous night infusion at increasing rate or by evening injections at different times on morning hyperglycemia and growth hormone levels in insulin-dependent diabetic patients.
    Lunetta M, Di Mauro M, Le Moli R.
    J Endocrinol Invest; 1998 Feb; 21(7):454-8. PubMed ID: 9766261
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of octreotide on plasma concentrations of glucose, insulin, glucagon, growth hormone, and cortisol in healthy dogs and dogs with insulinoma.
    Robben JH, van den Brom WE, Mol JA, van Haeften TW, Rijnberk A.
    Res Vet Sci; 2006 Feb; 80(1):25-32. PubMed ID: 15946716
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.